Related Experiment Video
Updated: Feb 26, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Intraperitoneal pyrophosphate treatment reduces renal calcifications in Npt2a null mice
Daniel Caballero1, Yuwen Li2,3, Jonathan Fetene1
1Department of Medicine, Section Endocrinology, Yale University School of Medicine, New Haven, CT, United States of America.
Abstract:
Mutations in the proximal tubular sodium-dependent phosphate co-transporters NPT2a and NPT2c have been reported in patients with renal stone disease and nephrocalcinosis, however the relative contribution of genotype, dietary calcium and phosphate, and modifiers of mineralization such as pyrophosphate (PPi) to the formation of renal mineral deposits is unclear. In the present study, we used Npt2a-/- mice to model the renal calcifications observed in these disorders. We observed elevated urinary excretion of PPi in Npt2a-/- mice when compared to WT mice. Presence of two hypomorphic Extracellular nucleotide pyrophosphatase phosphodiesterase 1 (Enpp1asj/asj) alleles decreased urine PPi and worsened renal calcifications in Npt2a-/- mice. These studies suggest that PPi is a thus far unrecognized factor protecting Npt2a-/- mice from the development of renal mineral deposits. Consistent with this conclusion, we next showed that renal calcifications in these mice can be reduced by intraperitoneal administration of sodium pyrophosphate. If confirmed in humans, urine PPi could therefore be of interest for developing new strategies to prevent the nephrocalcinosis and nephrolithiasis seen in phosphaturic disorders.
Insights
Pyrophosphate (PPi) protects against kidney calcification in Npt2a-/- mice. Increasing urinary PPi levels may offer a novel strategy for preventing nephrocalcinosis and kidney stones in phosphaturic disorders.
Area of Science:
- Nephrology
- Mineral Metabolism
- Molecular Biology
Background:
- Mutations in phosphate transporters NPT2a and NPT2c are linked to kidney stones and nephrocalcinosis.
- The roles of genetics, diet, and pyrophosphate (PPi) in renal mineral deposit formation are not fully understood.
Purpose of the Study:
- To investigate the protective role of pyrophosphate (PPi) in a mouse model of renal calcification.
- To explore PPi as a potential therapeutic target for phosphaturic disorders.
Main Methods:
- Utilized Npt2a-/- mice to model renal calcifications.
- Assessed urinary PPi excretion in Npt2a-/- and wild-type (WT) mice.
- Examined the effect of hypomorphic Extracellular nucleotide pyrophosphatase phosphodiesterase 1 (Enpp1asj/asj) alleles on renal calcification.
- Administered sodium pyrophosphate intraperitoneally to evaluate its impact on calcification.
Main Results:
- Npt2a-/- mice exhibited elevated urinary PPi excretion compared to WT mice.
- Reduced urinary PPi in Npt2a-/- mice with Enpp1asj/asj alleles exacerbated renal calcifications.
- Intraperitoneal sodium pyrophosphate administration decreased renal calcifications in Npt2a-/- mice.
Conclusions:
- Urinary pyrophosphate (PPi) acts as a protective factor against renal mineral deposits in Npt2a-/- mice.
- Modulating urinary PPi levels may represent a novel therapeutic approach for nephrocalcinosis and nephrolithiasis.
- Further research in humans is warranted to confirm the therapeutic potential of urinary PPi.
More Related Videos
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi VI: Surgical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi V: Nursing Management